Introduction
Methods
Population
Exposure of interest
Control group
Outcomes of interest
Study eligibility
Information sources and search strategy
Data acquisition and extraction
Risk of bias assessment
Data analysis
Results
Study characteristics
First author, publication year | Country | Design | Definition of exposure | Definition of vaccine receipt | Participants | Overall Population size (N), follow-up time | Gender (% of females) and age breakdown | Statistical analysis method used | Covariates in adjusted model |
---|---|---|---|---|---|---|---|---|---|
Elderly | |||||||||
Bazargan, 2020 | United States | Cross-sectional | Depressive symptoms (Geriatric depression scale) | Influenza (ever received) | Older African-Americans living in Los Angeles service area 6 (community recruitment) over 65 | Total N = 620 | 65% females, mean age 74 yrs (SD 7.1) | Logistic regression | Age, educational attainment (years of school attendance), living arrangements (alone or partner/family), score for financial difficulty, continuity of medical care, satisfaction with medical care, disability status, self-rated health status, COPD |
Browne, 2019 | United States | Cohort study | Depression, PTSD, anxiety disorder, serious mental illness (bipolar disorder or schizophrenia), substance use disorder, any mental illness based on ICD-9 codes in outpatient visits | Influenza (last year) | US veterans within the Veterans Health Administration over 50 | Total N = 4,461,247, Follow-up time: 1 yr | 8.5/5.1% females (exp/contr), mean age 55.8/64.7 yrs (SD 13.8/15.1) for exp/contr | Descriptive analysis | None |
Buchwald, 2000 | United States | Retrospective medical record review | Depression (currently depressed, no further information) | Influenza (ever, last year), PCV (ever) | Natives Americans or Alaska Natives registered with Seattle Indian Health Board over 50 | Total N = 550 | 61% females, mean age 60.6 yrs | Logistic regression | Age, sex, marital status, insurance status, alcohol use, other substance use, smoking, purified protein derivative placement, number of health problems, cardiovascular disease, pulmonary disease, diabetes, medication taken |
Druss, 2001 | United States | Cross-sectional | Psychiatric disorder (excl. substance disorder), substance use disorder, psychiatric disorder (incl. substance use disorder) based on ICD-9 codes | Influenza (ever, last year) | US-veterans registered with the Veterans Health Administration with high-comorbidities | Total N = 113,505 | 21/13.2% females (exp/contr) , mean age 60.8/66 years (SD 12.9/11.5) for exp/contr | Logistic regression | Age, gender, ethnicity, distance to VHA centre, disability caused by military service, health status, facility-level variables, medical comorbidity |
Howard, 2006 | United States | Cross-Sectional | Depression (self-reported) | Influenza (ever), PCV (ever) | Enrolled patients in Prudential Center for Health care research (US) | Total N = 3,260 | 56%/58% females, 65/62% 65–75 yrs, 30/31% 75-84yrs, 5/7% > 85yrs (with and without high school education) | Logistic regression | Health literacy, HS degree, age, gender, race, site, comorbidity, income, smoker |
Lawrence, 2020 | United States | Cross-sectional | Depression, anxiety, substance and drug abuse (results not reported) | Influenza (ever) | Primary care data registry, patients between 60 and 80 years old | Total N = 4,120 | 59.1/44.8% females (exp/contr), mean age 70.8/73.9 yrs for exp/contr | Logistic regression | Socioeconomic status, comorbidity index, diagnosis of influenza, pneumonia or other respiratory diseases, prescription of antidepressants and benzodiazepines, previous vaccine and health care utilisation |
Lin, 2016 | United States | Cross-sectional | Psychological distress (questionnaire) | Influenza (ever) | Participants from the medical expenditure panel survey over 65 | Total N = 3,658 | 57.5/44.8% females (exp/contr), mean age 74.8/73.9 yrs for exp/contr | Logistic regression | Socioeconomic status, region, comorbidity index, SF-12 score, BMI, metropolitan statistical area, smoking |
Mangtani, 2005 | United Kingdom | Cohort study | Dementia and depression (questionnaires) | Influenza (last year) | Participants over 74 from MCR trial of assessment and management of older people in the community | Total N = 5,572, Follow-up time 5yrs | 47% females, adults > 74 yrs | descriptive | None |
Peytremann-Bridenvaux, 2008 | Austria, Denmark, France, Germany, Greece, Italy, Netherlands, Spain, Sweden and Switzerland | Cross-sectional | Depression (questionnaire) | Influenza (last year) | Participants over 65 in the survey of Health, Ageing, and Retirement in 10 different European countries | Total N = 15,380 | 70.5/48.3% females (exp/contr) 56.4/46% over 65 yrs (exp/contr) | Logistic regression | Age, gender, socioeconomic status, behavioural risk, chronic disease, disability, country of residence |
Shah, 2012 | United Kingdom | Cross-sectional | Dementia (Read codes) | Influenza (last year) | Patients registered in The Health Improvement Network (THIN) over 65 years | N (community) = 5,048 N (care homes) = 3,582 | 87.6/63.2% females (care homes/community-dwelling), mean age 85.5/74.7 yrs for care home/community | Logistic regression | Age, gender, community setting, registration length in care home, deprivation, comorbidities |
Thorpe, 2006 | United States | Cross-sectional | Psychological distress (questionnaire) | Influenza (last year) | Participants over 65 in the Medical Expenditure Panel Survey | Total N = 3,566 | 58% females, mean age 74.4 yrs | Logistic regression | Age, gender, ethnicity, marital status, education, risk taking attitudes, beliefs about value of medical care, region, metropolitan area, physical health |
Adults | |||||||||
Nicolaidis, 2012 | United States | Cross-sectional | Autism spectrum disorder (self-reported and questionnaires) | Tetanus vaccine within the last 10 years | Online convenience sample | Total N = 437 | 36.7/42.2% females (exp/contr), mean age 37.3/39.7 yrs (SD 12.9/12.9) for exp/contr | Logistic regression | Age, sex, ethnicity, personal and parental education, income, health insurance, overall health status |
Xiang, 2015 | United States | Cohort study | Depression (questionnaire) | Influenza vaccine within the last two years | Participants over 50, enrolled in primary care register, without chronic disease at start | Total N = 11,439 | 55.4% females, mean age 61.4 yrs | Logistic regression | Age, gender, ethnicity, education, marital status, employment status, household wealth, activity of daily living difficulties, any chronic disease |
Mother and their children | |||||||||
Gilbert, 2021 | United States | Cross-sectional | General mental health score (questionnaire) | Childhood immunisation (not further specified) | Low-income mothers, enrolled in other longitudinal study | Total N = 843 | 100% females, mean age 28.8yrs (SD 6.0) | Logistic regression | Mother’s age, child’s age, ethnicity, mother’s education |
Lyman, 2008 | United States | Cohort study | Depression (questionnaire) | IPV, MMR and DTP vaccine at 24 months | Participants of the national maternal and infant health survey | Total N (mother baby pairs) = 7,296 | 59.1% females, mean age 70.8 yrs (SD 4.4) | Logistic regression | Poverty, single-parenthood, marital status, maternal ethnicity, wantedness of child, education, employment, health insurance of the child |
Lyngsoe, 2018 | Denmark | Cohort study | Depression (diagnoses and medication in health records) | DTP and MMR at 24 months | Mothers and their children in the Danish primary care data base | N (Children) = 850,243 N (Mothers) = 517,107 Follow-up time 13yrs | 100% females, mean age 30.6 yrs (SD 4.9) | Poisson regression | Household income, parents occupation and education level, number of siblings, maternal age at birth, mental health comorbidity, paternal depression |
Minkovitz, 2004 | United States | Cohort Study | Depression (questionnaire) | DTP, IPV, MMR at 24 months | Family samples from the Healthy steps for young children cohort study | Total N (families) = 5,565 Follow-up time 3 yrs | 100% females, 13.3% < 20 yrs, 50.5% 20–29 yrs, 36.2% > 30 yrs | Logistic regression | Mother’s age and ethnicity, parent’s employment status, child’s gender, household income, home ownership, children’s insurance status, birth weight, child’s health status, enrolment site |
Osam, 2020 | United Kingdom | Cohort study | Depression, anxiety, psychosis, eating disorder, personality disorder, alcohol and drug use (read codes) | MMR and 5-in-1 booster at age 2 and 5 | Mothers and their children in nationwide primary care data set (CPRD) | N (mothers) after 2 years = 479,949 N (mothers) after 5 years = 326,082 Follow-up time 12 yrs | 100% females, mean age 30.3 yrs (SD 5.8) | Logistic regression | Sex of child, child’s ethnicity, delivery year, maternal age, socioeconomic status, region |
Turner, 2003 | Australia | Cohort study | Depression, anxiety or combination | DTP, IPV, HiB at 7 months | Women from the Royal Women’s Hospital in Brisbane | Total N (mothers) = 159 Follow-up time = 6 months | 100% females, mean age 30.3 yrs (range 17–42 yrs) | Logistic regression | Mother’s age and income |
Children | |||||||||
Ankustiri, 2012 | United States | Cohort study | Autism spectrum disorder | HBV, DTP. PCV, IPV, MMR completed up to age 5 | Children participating in the Autism Phenome Project | Total N = 240 Follow-up time 5 yrs | 18% females, age between 2–5 yrs | Descriptive analysis | None |
Kuwaik, 2006 | Canada | Cross-sectional | Autism spectrum disorder (DSM-IV) | MMR at 12 months, DTP \t 2, 4, 6, and 18 months | Sub-sample from Canadian Autism Cohort study | N (children) = 98 N (siblings) = 98 | 32.6% females, age between 0-18yrs | ANOVA for group differences | None |
Tuffrey, 2001 | United Kingdom | Cross-sectional | Learning disability (approximated by special school attendance) | DTP, IPV, MMR, VAR (year 4) HPV, MCV4, DTP (year 11) | Children attending special schools in Bath clinical area | Total N = 408 | 36.7% females, age between 4–16 yrs | Chi-square tests | Maternal age, ethnicity, month and year of birth, child’s sex and birth site (for matching) |
Zerbo, 2012 | United States | Cohort study | Autism spectrum disorder (ICD-9 codes) | DTP, PCV, IPV, MMR, Var, HPV, MCV4, overall childhood immunisations completed in period of age 1–2 years, 4–6 years and 11–12 years | Members of the integrated health care delivery system | Total N = 596,633 Follow-up time 15 yrs | 18.1/46% females (exp/contr), 76.5% 4–6 yrs old, 23.5% 11–12 yrs old | Logistic regression | Maternal age, ethnicity, month and year of birth, sex of the child and birth site |
Risk of bias assessment
Author | Country | Study design | Risk of confounding | Risk of Selection Bias | Risk of non-differential misclassification of the exposure | Risk of non-differential misclassification of the outcome | Information bias of exposure | Information bias of outcome | Reverse causation |
---|---|---|---|---|---|---|---|---|---|
Ankustiri et al. (2012) | United States | cohort study | High | High | NA | NA | NA | Low | NA |
Browne et al. (2019) | United States | High | High | Moderate | Low | Moderate | Low | NA | |
Kuwaik et al. (2014) | Canada | High | High | Low | Moderate | Moderate | Moderate | Low | |
Lyman (2008) | United States | Low | High | Low | Moderate | Low | High | NA | |
Lyngsoe et al. (2018) | Denmark | Moderate | Moderate | Moderate | Low | Moderate | Low | Low | |
Mangtani et al.(2005) | United Kingdom | High | High | Low | Low | Low | High | Moderate | |
Minkovitz et al. (2004) | United States | Moderate | Moderate | Low | Moderate | High | Low | Low | |
Osam et al. (2020) | United Kingdom | Low | Moderate | Moderate | Low | Moderate | Low | Low | |
Turner et al. (2003) | United States | High | Moderate | Low | Low | Low | Low | Low | |
Xiang (2015) | United States | Moderate | High | Low | High | Low | High | Low | |
Zerbo et al. (2018) | United States | Moderate | High | Low | Low | Moderate | Low | Low | |
Bazargan et al. (2020) | United States | cross-sectional study | Low | High | Low | High | Low | High | moderate |
Buchwald et al. (2000) | United States | Low | High | NA | Low | Moderate | Low | moderate | |
Druss et al. (2001) | United States | Low | High | Moderate | Low | Moderate | Low | NA | |
Gilbert et al. (2021) | United States | Low | High | Moderate | High | Low | High | moderate | |
Howard et al. (2006) | United States | Low | High | High | High | Moderate | High | moderate | |
Lawrence et al. (2020) | United States | Low | High | Low | Low | Moderate | Low | moderate | |
Lin et al. (2016) | United States | Low | High | Low | High | Low | High | moderate | |
Nicolaidis et al. (2012) | United States | Low | High | High | High | Low | High | Low | |
Peytremann-Bridenvaux et al. (2008) | 10 European countries (Austria, Denmark, France, Germany, Greece, Italy, Netherlands, Spain, Sweden and Switzerland) | Low | High | Low | High | High | High | Moderate | |
Shah et al. (2012) | United Kingdom | Low | Moderate | Moderate | Low | Moderate | Low | Low | |
Thorpe et al. (2006) | United States | Low | High | Low | High | Low | High | Moderate | |
Tuffrey et al. (2001) | United Kingdom | High | High | High | Low | High | Low | Low |